Therefore, this finding prompts the question of whether a direct link exists between HOTAIR and miR-122 in promoting HCV-HCC, and if so, what would be the therapeutic implications of a combined therapy with HOTAIR antisense drugs? This evidence concerns the gene HOTAIR and hepatocellular carcinoma.